Caxton Corporation’s Alcentra Capital Corp ABDC Stock Holding History

Caxton Corporation’s Portfolio ABDC Stock Details ABDC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,005,000	Closed	-$9.1M	–	42
2019 Q4	$9.1M	Buy	1,005,000 +5,000	+0.5%	+$44.9K	8.77%	4
2019 Q3	$8.89M	Buy	1,000,000 +161,160	+19%	+$1.39M	10.02%	4
2019 Q2	$7.03M	Buy	838,840 +38,840	+5%	+$320K	7.98%	5
2019 Q1	$6M	Buy	800,000 +724,697	+962%	+$5.23M	5.57%	8
2018 Q4	$487K	Buy	75,303 +17,626	+31%	+$110K	0.59%	12
2018 Q3	$345K	Buy	57,677 +2,318	+4%	+$14.5K	0.32%	20
2018 Q2	$354K	Sell	55,359 -8,777	-14%	-$58.5K	0.13%	16
2018 Q1	$446K	Buy	64,136 +4,574	+8%	+$35.3K	0.48%	15
2017 Q4	$500K	Buy	+59,562	New	+$530K	0.61%	12

Caxton Corporation's ABDC Position: Q1 2020 in Review

Caxton Corporation sold out of Alcentra Capital Corp (ABDC) in Q1 2020, closing a stake of 1,005,000 shares — an estimated $9.1M sold.

Caxton Corporation first reported a position in ABDC in Q4 2017 and held it in 9 quarters. The position peaked at $9.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold ABDC as of Q1 2020.

Caxton Corporation reported no remaining Alcentra Capital Corp position as of Q1 2020 after selling out during the quarter.
Caxton Corporation sold 1,005,000 Alcentra Capital Corp shares in Q1 2020, an estimated $9.1M.
Caxton Corporation first reported a position in Alcentra Capital Corp in Q4 2017 and held it in 9 quarters.
Caxton Corporation's Alcentra Capital Corp position peaked at $9.1M in Q4 2019.
0 funds tracked by Wall St. Rank held Alcentra Capital Corp as of Q1 2020.

Based on Caxton Corporation's 13F filing for Q1 2020, filed 15 May 2020.